MIRA INFORM REPORT

 

 

Report Date :

28.01.2013

 

IDENTIFICATION DETAILS

 

Name :

MEDIPLANTEX NATIONAL PHARMACEUTICAL JOINT STOCK COMPANY

 

 

Registered Office :

No. 358, Giai Phong Street, Phuong Liet Ward, Thanh Xuan District, Ha Noi City

 

 

Country :

Vietnam

 

 

Financials (as on) :

30.06.2012

 

 

Date of Incorporation :

1958

 

 

Com. Reg. No.:

0100108430

 

 

Legal Form :

Joint stock company

 

 

Line of Business :

Trading in pharmaceutical products, cosmetics, nutritional foods

 

 

No. of Employees :

500

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Vietnam

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

vietnam - ECONOMIC OVERVIEW

 

Vietnam is a densely-populated developing country that in the last 30 years has had to recover from the ravages of war, the loss of financial support from the old Soviet Bloc, and the rigidities of a centrally-planned economy. While Vietnam's economy remains dominated by state-owned enterprises, which still produce about 40% of GDP, Vietnamese authorities have reaffirmed their commitment to economic liberalization and international integration. They have moved to implement the structural reforms needed to modernize the economy and to produce more competitive export-driven industries. Vietnam joined the World Trade Organization in January 2007 following more than a decade-long negotiation process. Vietnam became an official negotiating partner in the developing Trans-Pacific Partnership trade agreement in 2010. Agriculture's share of economic output has continued to shrink from about 25% in 2000 to about 22% in 2011, while industry's share increased from 36% to 40% in the same period. Deep poverty has declined significantly, and Vietnam is working to create jobs to meet the challenge of a labor force that is growing by more than one million people every year. The global recession has hurt Vietnam's export-oriented economy, with GDP in 2009-11 growing less than the 7% per annum average achieved during the last decade. In 2011, exports increased by more than 33%, year-on-year, and the trade deficit, while reduced from 2010, remained high, prompting the government to maintain administrative trade measures to limit the trade deficit. Vietnam's managed currency, the dong, continues to face downward pressure due to a persistent trade imbalance. Since 2008, the government devalued it in excess of 20% through a series of small devaluations. Foreign donors pledged nearly $8 billion in new development assistance for 2011. However, the government's strong growth-oriented economic policies have caused it to struggle to control one of the region's highest inflation rates, which reached as high as 23% in August 2011 and averaged 18% for the year. In February 2011, Vietnam shifted its focus away from economic growth to stabilizing its economy and tightened fiscal and monetary policies. In early 2012 Vietnam unveiled a broad "three pillar" economic reform program, proposing the restructuring of public investment, state-owned enterprises and the banking sector. Vietnam's economy continues to face challenges from low foreign exchange reserves, an undercapitalized banking sector, and high borrowing costs. The near-bankruptcy and subsequent default of the state-owned-enterprise Vinashin, a leading shipbuilder, led to a ratings downgrade of Vietnam's sovereign debt, exacerbating Vietnam's borrowing difficulties.

 

Source : CIA

 

 


SUBJECT IDENTIFICATION & LEGAL FORM

 

Current legal status

Registered English Name

 

MEDIPLANTEX NATIONAL PHARMACEUTICAL JOINT STOCK COMPANY

Registered Vietnamese Name

 

CONG TY CO PHAN DUOC TRUNG UONG MEDIPLANTEX

Trade name

 

MP

Registered Short name

 

MEDIPLANTEX., JSC

Type of Business

 

Joint stock company

Year Established

 

1958

Establishment Decision

 

4410/QD-BYT

Date of Issuance

 

07 Dec 2004

Place of Issuance

 

Ministry of Health

Business Registration No.

 

0100108430

Date of Registration

 

24 Aug 2010

Place of Registration

 

Hanoi Department of Planning and Investment

Chartered capital

 

VND 50,241,000,000

Status

 

Public Company

Stock symbol

 

MED

Stock Market

 

OTC

Tax code

 

0100108430

Total Employees

 

500

Size

 

Large

 

Historical Identification & Legal form

 

List

Changed Items

Date of changes

1

Subject has got former Board Of Director: General Director: Mrs. DOAN THI HONG THUY Changed to: Mr. PHUNG MINH DUNG

28 May 2012

2

Subject has got former Business Registration No: 0103007436

Changed to: 0100108430

24 Aug 2010

3

Subject has got former Chartered capital: VND 50,136,000,000

Changed to: VND 50,241,000,000

03 Jun 2008

4

Subject has got former Registered Vietnamese Name: CONG TY DUOC LIEU TRUNG UONG 1

Changed to: CONG TY CO PHAN DUOC TRUNG UONG MEDIPLANTEX

12 Apr 2005

5

Subject has got former Registered English Name: NATIONAL MEDICINAL PLANT COMPANY NO.I

Changed to: MEDIPLANTEX NATIONAL PHARMACEUTICAL JOINT-STOCK COMPANY

12 Apr 2005

6

Subject has got former Business Registration No: 108216, Issuance on May 22nd 1993 Changed to: 0103007436

12 Apr 2005

7

Subject has got former Type of Business: State owned company

Changed to: Joint stock company (pursuant to decision No 4410/QD-BYT)

07 Dec 2004

8

Subject has got former Registered Vietnamese Name: CONG TY THUOC NAM – THUOC BAC

Changed to: CONG TY CONG TY DUOC LIEU CAP I

Changed to: CONG TY DUOC LIEU TRUNG UONG 1

01 Jan 1984

 

 

 

ADDRESSES

 

Head Office

Address

 

No. 358, Giai Phong Street, Phuong Liet Ward, Thanh Xuan District, Ha Noi City, Vietnam

Telephone

 

(84-4) 3864 3368 /3367 / 3363 /3360 /3664 3841

Fax

 

(84-4) 3864 1584 /3668 6554

Email

 

meplan@fpt.vn

Website

 

www.mediplantex.com

Note: The given phone number “0913599926” is mobile phone of Mr. Nguyen Cong Binh - Import & Export Dep.

 

Factory Address

Address

 

Trung Hau Hamlet, Tien Phong Commune, Me Linh District, Ha Noi City, Vietnam

Tax code No.

 

0100108430-007

 

Branch in Ho Chi Minh

Address

 

No.270, Ly Thuong Kiet St., Ward 14, District 10, Ho Chi Minh City, Vietnam

Manager

 

Mr. VU ANH TUAN

Tax code No.

 

0100108430-001

 

Branch in Bac Giang

Address

 

No.25, Dang Thi Nho St., Ngo Quyen Ward, Bac Giang City, Bac Giang Province, Vietnam

Telephone

 

(84-240) 3856 777

Fax

 

(84-240) 3554 565

Tax code No.

 

0100108430-005

 

 

DIRECTORS

 

1. NAME

 

Mr. TRAN BINH DUYEN

Position

 

Chairman

Date of Birth

 

02 Mar 1947

ID Number/Passport

 

011800636

ID Issue Date

 

23 Jul 1993

ID Issue Place

 

Police of Hanoi city

Resident

 

No.10, 183 Alley Dang Tien Dong, Trung Liet Ward, Dong Da District, Ha Noi City, Vietnam

Nationality

 

Vietnamese

Tel/Mobile phone

 

(84-4) 38643363

 

2. NAME

 

Mr. PHUNG MINH DUNG

Position

 

General Director and Legal Representative

Date of Birth

 

17 Oct 1973

ID Number/Passport

 

011927545

ID Issue Date

 

10 Oct 2007

ID Issue Place

 

Hanoi Police Station

Resident

 

No.98, Group 12, Lane 99, Dinh Cong St., Dinh Cong Ward, Hoang Mai District, Ha Noi City, Vietnam

Nationality

 

Vietnamese

Tel/Mobile phone

 

(84-4) 38643363

 

3. NAME

 

Ms. NGUYEN THI TOAN

Position

 

Deputy General Director and Chief Accountant

Nationality

 

Vietnamese

Tel/Mobile phone

 

(84-4) 38643363

 

4. NAME

 

Mr. HA XUAN SON

Position

 

Deputy General Director

Nationality

 

Vietnamese

Tel/Mobile phone

 

(84-4) 38643363

 

 

BUSINESS NATURE AND ACTIVITIES

 

- Trading in pharmaceutical products, cosmetics, nutritional foods
- Trading in materials for pharmaceutical production
- Import and export service
- Trading medical equipments

 

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT:

Types of products

 

Materials

Market

 

Canada (Tenamid Corp), Denmark, France, India, Korea …

Mode of payment

 

L/C; T/T

 

EXPORT:

Market

 

France, Germany, Japan, China, Laos, Cambodia, Russia …

Mode of payment

 

L/C; T/T

 

 

 

BANKERS

 

1. JOINT STOCK COMMERCIAL BANK FOR FOREIGN TRADE OF VIETNAM TRANSACTION CENTER

Address

 

No 31 -33 Ngo Quyen, Hoan Kiem District, Ha Noi City, Vietnam

Telephone

 

(84-4) 39368547

Fax

 

(84-4) 38241395 / 39365534

 

2. BANK FOR INVESTMENT AND DEVELOPMENT OF VIETNAM THANG LONG BRANCH

Address

 

No.8 Pham Hung, Cau Giay District, Ha Noi City, Vietnam

Telephone

 

(84-4) 3838 7118

Fax

 

(84-4) 3836 3704

 

3. VIET NAM BANK FOR AGRICULTURE AND RURAL DEVELOPMENT LANG HA BRANCH

Address

 

No.24 Lang Ha Street, Dong Da District, Ha Noi City, Vietnam

Telephone

 

(84-4) 37763773

Fax

 

(84-4) 38312250

VND Account

 

1400.311.0102.79

 

 

SHAREHOLDERS

 

1. NAME

 

VIETNAM PHARMACEUTICAL CORPORATION

Business Registration

 

0106001031

Date of Registration

 

16 Dec 2008

Place of Registration

 

Ha Noi City Department of Planning and Investment

Representative

 

HA XUAN SON

Registered Capital

 

VND 1,338,544,248,430

Tax code

 

0100109385

Address

 

No.138B Giang Vo Str, Ba Dinh District, Ha Noi City, Vietnam

Tel

 

(84-4) 3844 3153/ 3844 3151

Fax

 

(84-4) 3844 3665

Email

 

vinapharm@hn.vnn.vn

Website

 

http://www.vinapharm.net.vn

Number of shares

 

571,000

Value of shares

 

VND 5,710,000,000

Percentage

 

11.37%

 

2. NAME

 

663 OTHER SHAREHOLDERS

Number of shares

 

4,453,100

Value of shares

 

VND 44,531,000,000

Percentage

 

88.63%

 

 

 

FINANCIAL DATA

 

BALANCE SHEET

Unit: One VND

Balance sheet date

30/06/2012

31/12/2011

31/12/2010

Number of weeks

26

52

52

Audit status

Unaudited

Audited

Unknown

ASSETS

A – CURRENT ASSETS

280,018,724,093

248,510,103,443

195,510,031,165

I. Cash and cash equivalents

6,705,867,297

5,821,346,648

6,648,109,322

1. Cash

6,705,867,297

5,821,346,648

6,648,109,322

2. Cash equivalents

0

0

0

II. Short-term investments

0

0

0

1. Short-term investments

0

0

0

2. Provisions for devaluation of short-term investments

0

0

0

III. Accounts receivable

166,112,133,200

160,077,644,309

117,382,297,896

1. Receivable from customers

160,332,542,763

156,492,390,954

112,086,828,032

2. Prepayments to suppliers

5,521,489,688

3,147,812,858

4,338,082,437

3. Inter-company receivable

0

0

0

4. Receivable according to the progress of construction

0

0

0

5. Other receivable

758,100,749

937,440,497

957,387,427

6. Provisions for bad debts

-500,000,000

-500,000,000

0

IV. Inventories

98,330,262,395

79,463,185,220

69,028,655,278

1. Inventories

98,686,471,339

80,029,593,368

69,366,372,110

2. Provisions for devaluation of inventories

-356,208,944

-566,408,148

-337,716,832

V. Other Current Assets

8,870,461,201

3,147,927,266

2,450,968,669

1. Short-term prepaid expenses

921,861,406

51,882,816

0

2. VAT to be deducted

1,118,567,153

1,130,290,397

860,045,601

3. Taxes and other accounts receivable from the State

0

2,412,592

0

4. Other current assets

6,830,032,642

1,963,341,461

1,590,923,068

B. LONG-TERM ASSETS

84,241,309,368

88,894,825,560

94,281,063,015

I. Long term accounts receivable

0

0

0

1. Long term account receivable from customers

0

0

0

2. Working capital in affiliates

0

0

0

3. Long-term inter-company receivable

0

0

0

4. Other long-term receivable

0

0

0

5. Provisions for bad debts from customers

0

0

0

II. Fixed assets

71,629,041,016

74,915,262,357

78,836,540,877

1. Tangible assets

69,214,554,997

71,347,711,018

62,752,837,108

- Historical costs

115,115,079,302

114,562,937,241

98,641,493,475

- Accumulated depreciation

-45,900,524,305

-43,215,226,223

-35,888,656,367

2. Financial leasehold assets

0

0

0

- Historical costs

0

0

0

- Accumulated depreciation

0

0

0

3. Intangible assets

882,843,378

929,136,510

782,322,774

- Initial costs

1,116,125,328

1,116,125,328

910,925,328

- Accumulated amortization

-233,281,950

-186,988,818

-128,602,554

4. Construction-in-progress

1,531,642,641

2,638,414,829

15,301,380,995

III. Investment property

0

0

0

Historical costs

0

0

0

Accumulated depreciation

0

0

0

IV. Long-term investments

100,000,000

100,000,000

1,395,523,427

1. Investments in affiliates

0

0

0

2. Investments in business concerns and joint ventures

0

0

0

3. Other long-term investments

100,000,000

100,000,000

1,395,523,427

4. Provisions for devaluation of long-term investments

0

0

0

V. Other long-term assets

12,512,268,352

13,879,563,203

14,048,998,711

1. Long-term prepaid expenses

12,512,268,352

13,879,563,203

14,048,998,711

2. Deferred income tax assets

0

0

0

3. Other long-term assets

0

0

0

VI. Goodwill

0

0

0

1. Goodwill

0

0

0

TOTAL ASSETS

364,260,033,461

337,404,929,003

289,791,094,180

 

LIABILITIES

A- LIABILITIES

264,231,759,983

233,006,872,721

187,261,576,302

I. Current liabilities

264,029,202,182

230,629,304,575

181,804,406,579

1. Short-term debts and loans

107,251,424,981

88,695,472,649

98,181,235,472

2. Payable to suppliers

119,289,883,233

112,969,388,732

61,084,681,205

3. Advances from customers

6,277,638,885

3,207,485,635

1,878,613,024

4. Taxes and other obligations to the State Budget

1,859,183,201

3,114,563,467

1,257,389,626

5. Payable to employees

1,003,036,223

1,508,496,423

772,063,701

6. Accrued expenses

7,352,718,259

3,531,241,284

1,530,424,507

7. Inter-company payable

0

0

0

8. Payable according to the progress of construction contracts

0

0

0

9. Other payable

20,634,039,622

17,289,190,412

17,099,999,044

10. Provisions for short-term accounts payable

0

0

0

11. Bonus and welfare funds

361,277,778

313,465,973

0

II. Long-Term Liabilities

202,557,801

2,377,568,146

5,457,169,723

1. Long-term accounts payable to suppliers

0

0

0

2. Long-term inter-company payable

0

0

0

3. Other long-term payable

29,907,669

2,204,918,014

0

4. Long-term debts and loans

0

0

5,397,556,123

5. Deferred income tax payable

0

0

0

6. Provisions for unemployment allowances

172,650,132

172,650,132

59,613,600

7. Provisions for long-term accounts payable

0

0

0

8. Unearned Revenue

0

0

0

9. Science and technology development fund

0

0

0

B- OWNER’S EQUITY

100,028,273,478

104,398,056,282

102,529,517,878

I. OWNER’S EQUITY

99,385,080,520

103,638,241,245

101,214,985,622

1. Capital

50,241,000,000

50,241,000,000

50,241,000,000

2. Share premiums

42,083,900,000

42,083,900,000

42,083,900,000

3. Other sources of capital

0

0

0

4. Treasury stocks

0

0

0

5. Differences on asset revaluation

0

0

0

6. Foreign exchange differences

118,911,810

36,676,730

-346,579,693

7. Business promotion fund

1,719,528,632

1,719,528,632

1,531,134,413

8. Financial reserved fund

2,952,295,213

2,952,295,213

2,763,900,994

9. Other funds

0

0

0

10. Retained earnings

2,269,444,865

6,604,840,670

4,941,629,908

11. Construction investment fund

0

0

0

12. Business arrangement supporting fund

0

0

0

II. Other sources and funds

643,192,958

759,815,037

1,314,532,256

1. Bonus and welfare funds (Elder form)

0

0

294,649,573

2. Sources of expenditure

0

0

24,230,882

3. Fund to form fixed assets

643,192,958

759,815,037

995,651,801

MINORITY’S INTEREST

0

0

0

TOTAL LIABILITIES AND OWNER’S EQUITY

364,260,033,461

337,404,929,003

289,791,094,180

 

 

PROFIT & LOSS STATEMENT

 

Description

6 months

of 2012

FY2011

FY2010

1. Total Sales

241,597,434,652

589,688,438,730

494,342,400,519

2. Deduction item

768,987,198

2,593,110,481

5,508,266,430

3. Net revenue

240,828,447,454

587,095,328,249

488,834,134,089

4. Costs of goods sold

205,536,964,133

514,387,443,828

431,497,461,047

5. Gross profit

35,291,483,321

72,707,884,421

57,336,673,042

6. Financial income

322,175,985

959,684,921

1,392,498,815

7. Financial expenses

8,058,842,773

20,552,040,130

16,383,675,943

- In which: Loan interest expenses

7,992,287,202

19,395,947,492

15,248,303,458

8. Selling expenses

17,739,787,603

30,431,732,866

22,215,974,710

9. Administrative overheads

8,311,920,654

15,860,641,228

15,398,336,482

10. Net operating profit

1,503,108,276

6,823,155,118

4,731,184,722

11. Other income

22,709,096

428,072,057

494,455,169

12. Other expenses

118,099,230

43,594,271

182,162,968

13. Other profit /(loss)

-95,390,134

384,477,786

312,292,201

14. Total accounting profit before tax

1,407,718,142

7,207,632,904

5,043,476,923

15. Current corporate income tax

351,929,536

1,814,881,099

1,275,592,553

16. Deferred corporate income tax

0

0

0

17. Interest from subsidiaries/related companies

0

0

0

18. Profit after tax

1,055,788,606

5,392,751,805

3,767,884,370

 

 

FINANCIAL RATIOS AND AVERAGE INDUSTRY RATIOS

 

Description

6 months

of 2012 

FY2011

FY2010

Average Industry

Current liquidity ratio

1.06

1.08

1.08

1.65

Quick liquidity ratio

0.69

0.73

0.70

1.04

Inventory circle

2.31

6.47

5.65

4.14

Average receive period

251.76

99.52

87.65

105.37

Utilizing asset performance

0.66

1.74

1.69

1.20

Liability by total assets

72.54

69.06

64.62

53.11

Liability by owner's equity

264.16

223.19

182.64

159.74

Ebit / Total assets (ROA)

2.58

7.88

7.00

10.37

Ebit / Owner's equity (ROE)

9.40

25.48

19.79

23.03

Ebit / Total revenue (NPM)

3.89

4.51

4.10

10.15

Gross profit / Total revenue (GPM)

14.61

12.33

11.60

25.88

Note: The Average Industry was calculated by VietnamCredit based on our own statistical data

 

 

 

CASH FLOW STATEMENT

(Indirect method)

Items

6 months of 2012

FY2011

 

I. Cash flows from operating activities

1. Profit before tax

1,407,718,142

7,207,632,904

 

2. Adjustments

 

 

 

- Depreciation and amortization

4,398,757,798

7,674,928,656

 

- Provisions

-210,199,204

728,691,316

 

- Unrealized foreign exchange difference

118,911,810

36,676,730

 

- Gain/loss from investing activities

-100,665,130

-1,018,901,310

 

- Interest expense

7,992,287,202

19,395,947,492

 

3. Operating profit before movements in working capital

13,606,810,618

34,024,975,788

 

- (Increase)/Decrease in receivables

-5,997,502,227

-43,740,422,194

 

- (Increase)/Decrease in inventories

-18,356,877,971

-10,663,221,258

 

- Increase/(Decrease) in accounts payable

15,729,782,523

57,005,948,473

 

- (Increase)/Decrease in prepaid expenses

597,316,261

117,552,692

 

- Interest paid

-7,992,287,202

-19,395,947,492

 

- Corporate income tax paid

-1,278,912,022

-972,901,199

 

- Other cash inflows

0

0

 

- Other cash outflows

-4,069,635,000

-118,290,882

 

Net cash from (used in) operating activities

-7,761,305,020

16,257,693,928

 

II. Cash flows from investing activities

 

1. Acquisition of fixed assets and other long - term assets

-5,853,137,303

-3,989,486,900

 

2. Proceeds from fixed assets and long - term assets disposal

0

356,192,870

 

3. Cash outflow for lending, buying debt instruments of other companies

0

898,546,946

 

4. Cash recovered from lending, selling debt instruments of other companies

0

0

 

5. Investment in other entities

0

0

 

6. Cash recovered from investments in other entities

0

0

 

7. Interest income, dividend and profit paid

322,175,985

959,684,921

 

Net cash from (used in) investing activities

-5,530,961,318

-1,775,062,163

 

III. Cash flows from financing activities

 

1. Proceeds from issuing stocks, receiving capital from owners

0

0

 

2. Capital withdrawal, buying back issued stocks

0

0

 

3. Proceeds from borrowings

153,928,305,043

324,258,066,400

 

4. Repayment of borrowings

-137,595,234,656

-336,936,467,332

 

5. Repayment of obligations under finance leased

0

0

 

6. Dividends paid

-2,156,283,400

-2,977,573,200

 

Net cash from (used in) financing activities

14,176,786,987

-15,655,974,132

 

Net increase/(decrease) in cash and cash equivalents

884,520,649

-1,173,342,367

 

Cash and cash equivalents at beginning of year

5,821,346,648

6,648,109,322

 

Effect from changing foreign exchange rate

-36,676,730

346,579,693

 

Cash and cash equivalents at end of year

6,705,867,297

5,821,346,648

 

 

 

PAYMENT HISTORY & PERFORMANCE EXPERIENCES

 

Trade Morality

 

Good

Liquidity

 

Medium

Payment status

 

Above Average

Financial Situation

 

Average

Development trend

 

Positive

Litigation data

 

No Record

Bankruptcy

 

No Record

Payment Methods

 

TT, L/C

Sale Methods

 

Retailer and Wholesaler

Public opinion

 

Excellent

 

 

 

INTERPRETATION ON THE SCORES

 

Beginning in 1958, MEDIPLANTEX., JSC has long history in the pharmaceutical industry and its position is fairly good. Its chartered capital has been increased to VND 50,241 million in 2008. At present, it is public company on OTC market with the stock symbol of MED. It planned to list on HNX (Hanoi Stock Exchange) in August 2012. However, the listing has been canceled by HNX because the subject did not complete procedures on time.

The subject has about 500 employees including office staffs and workers. Its facilities are quite good. Besides headquarters in Hanoi, the subject has branches in Hochiminh City and Bac Giang province. It has two factories: the first one was granted GMP-ASEAN certification since 2000; the second one ran into operation in June 2007 locating on an area of 20,000 m2 in Me Linh Dist., Hanoi (Vinh Phuc former), and it was certificated of GMP-WHO.

Through more than half century of existence and development, its trademark in Vietnam seems good. The subject has been allowed circulation over 150 kinds of high-quality products. Besides supplying in the local market, its products are exported to many countries in the world, in which 6 main markets including France, Australia, Germany, India, Japan, and Korea.

The financial situation of company is average. Looking at the following chart of company, we see that the total assets and owner’s equity has uptrend but the liabilities were relatively high. It made the liquidity and financial leverage ratios were humble in compared with the industry average.

 

Besides that, the revenue’s growth was not stable through years, and the profit was still humble (look at follow chart).

 

In short, the subject is ranked as a large-sized company in the industry. It is able to meet normal financial commitments.

 

INDUSTRY DATA

 

Industry code

Growth speed by price compared with 1994 (%)

Total enterprises 2010

Total employees 2011

(Thous.pers.)

Annual average capital of enterprises 2010

(billion dongs)

2011

2010

Agriculture, Forestry and Fishing

4.00

2.78

8,887

24,362.9

95,227

Industry and Construction

5.53

7.70

95,217

10,718.9

3,641,376

Trade and Services

6.69

7.52

187,195

15,270.2

6,957,082

 

ECONOMIC INDICATORS

 

 

2011 

2010 

2009 

Population (Million person)

87.84

86.93

86.02

Gross Domestic Products (USD billion)

119

102.2

91

GDP Growth (%)

5.89

6.78

5.32

GDP Per Capita (USD/person/year)

1,300

1,160

1,080

Inflation (% Change in Composite CPI)

18.58

11.75

6.88

State Budget Deficit compared with GDP (%)

4.9

5.8

6.9

 

SERVICE TRADE PERFORMANCE

 

Billion USD 

2011 

2010 

2009 

Exports

96.3

72.2

57.1

Imports

105.8

84.8

69.9

Trade Balance

-9.5

-12.6

-12.8

Source: General Statistics Office

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.85

UK Pound

1

Rs.85.25

Euro

1

Rs.71.72

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.